Precision Biosciences (DTIL) Operating Margin (QoQ) (2018 - 2026)

Precision Biosciences (DTIL) Operating Margin (QoQ) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Precision Biosciences 178.85 Mn 150.56 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -12,030.00
Dec 31, 2025 15.90 Mn
Sep 30, 2025 -3.74 Mn
Jun 30, 2025 -4.53 Mn
Mar 31, 2025 -7.24 Mn
Dec 31, 2024 -20,078.00
Sep 30, 2024 -374,197.00
Jun 30, 2024 7,220.00
Mar 31, 2024 18,775.00
Dec 31, 2023 -11,734.00
Sep 30, 2023 -7,842.00
Jun 30, 2023 13,628.00
Mar 31, 2023 -3,784.00
Dec 31, 2022 8,506.00
Sep 30, 2022 57,434.00
Jun 30, 2022 5,042.00
Mar 31, 2022 -33,941.00
Dec 31, 2021 -43,666.00
Sep 30, 2021 -7,946.00
Jun 30, 2021 14,608.00